INTRODUCTION
The genetic control of multi-antibiotic resistance expressed by Neisseria gonorrhoeae, as exemplified by the mtr (multiple transferable resistance) system, is of considerable interest because a single mutation can lead to resistance to not only antibiotics but also antibacterial compounds (e.g. fatty acids and bile salts) that bathe mucosal surfaces. Maness & Sparling (1973) initially described the mtr system and showed that it mediated resistance to a panel of hydrophobic agents (HAS) including drugs, dyes and detergents. Subsequent reports indicated that such resistant strains accounted for 12.5 % of all clinical isolates (Morse e t al., 1982 sensitivity to penicillin and HAS, due to mutations in env loci, often contained a phenotypically suppressed mutation in their mtrR gene (Eisenstein & Sparling, 1978) ; these strains could serve as genetic donors in the horizontal spread of HAR (Shafer et al., 1984) . The mtr system is a multi-gene complex consisting of the mtrR gene, encoding the MtrR transcriptional repressor protein (Pan & Spratt, 1994) , and three tandemly linked genes (mtrCDE) that are positioned 250 bp upstream and transcribed divergently from the mtrR gene (Hagman e t al., 1995) . The mtrCDE genes constitute a single transcriptional unit and encode proteins (MtrC, MtrD and MtrE) similar to the MexABOprK membrane proteins of Psezldomonas aerzlginosa (Poole e t al., 1993a) , which mediate bacterial resistance to antibiotics by an efflux-based mechanism (Poole e t al., 1993b) . Missense mutations in the mtrR-coding region (Pan & 0001-9525 0 1995 SGM Spratt, 1994 Hagman et a/., 1995) , as well as a single basepair deletion in the mtrR promoter region (Hagman et al., 1995) , were able to confer HAR when introduced by transformation into the HAS strain FA19. Since the frequency and importance of these mutations among clinical isolates was unknown, we determined the nucleotide sequence of mtrR genes from six strains isolated from patients with rectal gonorrhoea. These isolates were chosen for analysis because antibacterial faecal lipids have been proposed to select for HAR variants (Morse et al., 1982) . The results revealed that missense mutations that cause radical amino acid substitutions within the proposed DNA-binding domain of the MtrR protein of laboratoryderived strains also occur frequently in HAR clinical isolates.
METHODS
Gonococcal strains and growth conditions. The strains employed in this investigation and their levels of resistance to HAS are listed in Table 1 . Strains FA171 and BR87 are genetic derivatives of strain FA19 that were constructed in the 1970s (Sparling e t al., 1975; Sarubbi e t al., 1975) . Strain BR87, hypersusceptible to HAS, contains a missense mutation in codon 45 of its mtrR gene (Hagman e t al., 1995) that is phenotypically suppressed by an unlinked mutation, env-2 (Sarubbi e t al., 1975) . The presence of this missense mutation in strain BR87 prompted this investigation. Strain FA171 is a transformant of strain FA19. It was constructed (Sparling e t al., 1975) using donor DNA from an HAR mutant (FA48) derived from an HA hypersusceptible mutant (FA47) of strain FA19 (Sarubbi e t al., 1975) . Strains AP776, AP1058, AP1169, AP1192, NRL31115 and NRL31376 were rectal isolates obtained from non-partner homosexual men with gonorrhoea. These isolates were obtained in Seattle, Washington during the period of 1978-1980 and were previously found to be resistant to the antibacterial action of faecal lipids (Morse e t al., 1982) . They exhibited varying levels of resistance to HAS (Table 1 ). All strains were grown as P+Op-variants on GCB agar containing glucose and iron supplements (Shafer et al., 1984) under 343% (v/v) CO, at 37 OC.
Antimicrobial susceptibility testing. The minimal inhibitory concentrations (MIC) of the HAS crystal violet (CV), erythromycin (Ery) and Triton X-100 (TX-100) for the strains studied were determined as described previously (Shafer e t al. ,1984) and are presented in Table 1 .
PCR amplification and DNA sequencing. A chromosomal DNA sequence encompassing the 633 bp mtrR coding region, 120 bp of sequence information past the translational stop codon, and 272 bp of sequence information upstream of the translational start codon was obtained by PCR amplification of chromosomal DNA preparations (McAllister & Stephens, 1993) using the oligonucleotide primers CEL-1 (5' GACAATGTTC-ATGCGATGATAGG 3') and KH9#3 (5' GACGACAGTG-CCAATGCAACG 3'). PCR amplification was for 30 cycles using a two-step programme consisting of a 1 min denaturation at 95 "C followed by extension at 60 OC. PCR products for use in sequencing and transformation were purified by agarose gel electrophoresis and electroeluted into TBE buffer (9 mM Tris, 9 mM boric acid, 2 mM EDTA, pH 8.0); at least two independent lots of PCR-amplified D N A were obtained from each strain. D N A sequencing was performed using the above described oligonucleotide primers, labeled with [y3'P]ATP (NEN DuPont). The AmpliTaq cycle sequencing kit (Perkin Elmer) was used as recommended by the manufacturer.
Transformation. A 0.5 ml sample of a culture of strain FA19 (P' ) was incubated with 0.05 pg of agarose-gel-purified, PCRamplified DNA in transformation broth (Shafer e t al., 1984) for 0.5 h prior to plating onto GCB agar. After incubation for 5 h at 37 "C under 3.8% (v/v) CO,, transformants resistant to Ery (0.5 pg ml-l) were selected using an agar overlay procedure (Sparling e t al., 1975) . Transformants were screened for levels of resistance to CV, Ery and TX-100.
RESULTS

Deduced amino acid sequences of MtrR proteins
The nucleotide sequences of the mtrR-coding regions from the isogenic gonococcal strains FA19, FA171 and BR87, and the clinical isolates CH95 and 3035, were previously determined (Hagman et al., 1795; Pan & Spratt, 1774) . This information was used for comparison of their deduced respective MtrR protein sequences with those of the clinical isolates studied herein. As is shown in Fig. 1 , the MtrR protein of strain BR87 differed from that of parental strain FA17 by a single amino acid as a result of a missense mutation [GGC (glycine) to GAC (aspartic acid)] in codon 45. This missense mutation is likely to affect MtrR function because it occurs within the second helical domain of the proposed (Pan & Spratt, 1974) helix-turn-helix (HTH) motif, increasing the helical characteristics of the adjacent turn region. The mtrRcoding region from strains CH75 (isolated in Thailand in 1970) and 3035 (isolated in the UK in 1787) were previously shown (Pan & Spratt, 1974) to contain an identical missense mutation in codon 105 that replaced histidine with tyrosine at position 105, which is outside of the HTH motif.
Compared to strain FA17, all six HAR rectal isolates possessed nucleotide differences in their mtrR-coding sequences. Strain NRL31115 was of particular interest because it contained an 11 bp insert (5' TCTGCGACG-AC 3') at nucleotide position 204 that represented an exact duplication of nucleotides 173-203 of the mtrR-coding region. This duplication would result in the production of a protein of 117 amino acids with a C-terminal domain that diverges from the FA17 MtrR sequence at amino acid position 67 ( Fig. 1) and is truncated by 73 amino acids (data not presented). The other five rectal isolates lacked this duplication but each contained single missense mutations that resulted in radical amino acid replacements in their respective MtrR proteins. A missense mutation in codon 45 (GGC to GAC) occurred most frequently (strains AP1058, AP1167, AP1172 and NRL31376); this mutation was identical to that observed in the mtrR gene possessed by strain BR87. Strain AP776 contained a missense mutation in codon 40 (GCC to ACC), which resulted in the replacement of a hydrophobic amino acid (alanine) in the first helical domain of the H T H motif with a hydrophilic amino acid (threonine) (Fig. 1) .
Frequency of a deletion mutation in the mtrR promoter region
Hagman et al. (1975) demonstrated that the MtrR protein possessed by HAR strain FA171 had an identical amino acid sequence to that of its parental strain, FA19 (Fig. 1) . However, strain FA171 and the clinical isolate CH75 (Hagman etal., 1995) were found to have a single basepair (A/T) deletion in the 13 bp inverted repeat sequence located within the mtrR promoter region (Fig. 2 ). An examination of the DNA sequence upstream of the mtrR translational start codon in the six clinical isolates revealed that two (strains AP1169 and AP1172) contained this single bp deletion (Fig. 2 ) in addition to the missense mutation in codon 45.
Transforming activity of mtrR genes
In order to verify that the mutations described above were important in determining HAR in gonococci, the mtrR region was amplified by PCR from strains FA17, FA171, NRL31115, AP776, AP1167 and AP1058 and the gelpurified products were used to transform strain FA17 for increased resistance to HAS; 0-5 pg Ery ml-' was used in the selection. With the exception of the negative control PCR product from strain FA17, all PCR products displayed transforming activity ( Table 2 ). The presence of the donor mutations in representative transformants was confirmed by sequencing PCR-amplifed DNA products (data not presented).
Representative transformants were scored for levels of cross-resistance to CV and TX-100 and the results (Table  2) showed that the transformants expressed either intermediate or high levels of HAR. Differences in levels of HAR expressed by the transformant strains were most apparent with respect to TX-100 resistance (TX-lOOR). Thus, intermediate levels of TX-lOOR (0.5-2.0 mg TX-100 ml-l) were obtained when the donor DNA possessed only a missense mutation in codon 40 (strain AP776) or codon 45 (strain AP1058) or the nonsense mutation (strain NRL31115 $ The MIC value for donor strain FA19 is shown in Table 1. region with (strain AP1169) or without (strain AP171) an accompanying missense mutation in codon 45 were capable of transforming strain FA19 to high level TX-100R (> 16 mg TX-100 ml-'). The level of HAR expressed by transformants obtained with the FA171, NRL31115, AP776 and AP1169 PCR products resembled that of their respective donor strains (Table 1) . However, the level of HAR expressed by transformants obtained with the PCR product from strain AP1058 was less than that of the donor strain (Table 2) . This difference was more obvious with TX-1 OOR, suggesting that strain AP1058 contained a second but mtr-independent mechanism for resistance to the membrane-damaging action of this detergent. An mtr-independent mechanism for determining levels of gonococcal resistance to faecal lipids, which exert detergent-like action in membranes, has been previously proposed (McFarland e t al., 1983) and is supported by this data.
DISCUSSION
These results confirm and extend previous studies (Pan & Spratt, 1994; Hagman et a!., 1995) that implicated the MtrR protein as a regulator of HAR in gonococci. The similarity between MtrR and certain transcriptional repressors, notably those belonging to the tetracycline repressor family (Brow et al., 1985) , have led to the suggestion that MtrR may function to control expression of genes that are responsible for the efflux of HAS. Indeed, our recent studies (Hagman e t al., 1995) indicate that MtrR regulates expression of the tandemly linked mtrCDE genes because mutations in the mtrR-coding or upstream sequences results in enhanced levels of the MtrC lipoprotein. MtrC (Hagman e t al., 1995) shares more than 40% identity at the amino acid level to the MexA (Poole etal., 1993) , AcrA (Ma etal., 1993) and EnvC (Klein et al., 1991) lipoproteins that participate in the efflux of antimicrobial agents from P. aerzlginosa (MexA) and E. coli (AcrA and EnvC).
The missense mutation in codon 45 that we identified in four of the six clinical isolates was identical to that observed previously (Hagman et al., 1995) in a laboratoryderived strain (BR87). Since this mutation is phenotypically suppressed in strain BR87 by an unlinked mutation in the env-2 locus (Sarubbi e t al., 1975) High level HAR in gonococci due to the mtr system is dependent on a single basepair deletion located within the mtrR promoter region. This deletion is located within a novel 13 bp inverted repeat sequence (Fig. 2) 
